Role of chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) rechallenge in small cell transformation after EGFR-TKI failure: a case report

BACKGROUND: Small cell lung cancer (SCLC) transformation is one of the resistance mechanisms associated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). Rechallenge with the first-line TKI after the second-line chemotherapy is suggested as a salvage treatment despite m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Onco Targets Ther
Autors principals: Lee, Sanghun, Joo, Jeonghyun, Kwak, Minah, Sohn, Kicheul, Chon, Songha
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6042494/
https://ncbi.nlm.nih.gov/pubmed/30022837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S164764
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars